“We are very pleased to have been issued a research licence, which effectively paves the way forward for future domestic supply of medicinal cannabis, targeting multiple markets with high purity cannabidiol (CBD) and enabling THC to continue its roll out of high quality imported products as well as locally produced medicines.”

Analysis

THC will now advance research into medicinal cannabis to undertake both its own research exploring optimal cultivation and production methodologies and strain development.

The company will also look to the implementation of its epigenetic technology as a